Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-27 06:57 am Purchase | 2025-09-30 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | Sumitomo Mitsui Trust Group, Inc. | 1,947,835 7.200% | 21,751 (+1.13%) | Filing History |
| 2025-07-30 1:16 pm Sale | 2025-06-30 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | ARK Investment Management LLC | 1,715,040 6.320% | -332,647 (-16.25%) | Filing History |
| 2025-07-29 12:05 pm Purchase | 2025-06-30 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | The Vanguard Group | 1,810,165 6.670% | 351,785 (+24.12%) | Filing History |
| 2025-05-12 2:10 pm Sale | 2025-03-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | Nikko Asset Management Americas, Inc. | 1,926,084 7.100% | -389,210 (-16.81%) | Filing History |
| 2025-04-25 06:18 am Sale | 2025-03-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | Sumitomo Mitsui Trust Group, Inc. | 1,926,084 7.100% | -389,210 (-16.81%) | Filing History |
| 2025-04-23 8:14 pm Sale | 2025-03-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | BlackRock Inc. BLK | 2,104,537 7.800% | -638,465 (-23.28%) | Filing History |
| 2025-02-05 07:52 am Sale | 2024-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | STATE STREET CORP STT | 1,326,158 4.900% | -303,508 (-18.62%) | Filing History |
| 2024-11-08 3:17 pm Purchase | 2024-09-30 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | Nikko Asset Management Americas, Inc. | 2,315,294 8.560% | 994,642 (+75.31%) | Filing History |
| 2024-11-05 06:07 am Purchase | 2024-09-30 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | Sumitomo Mitsui Trust Group, Inc. | 2,315,294 8.560% | 994,642 (+75.31%) | Filing History |
| 2024-04-05 12:18 pm Purchase | 2024-03-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | BlackRock Inc. BLK | 2,743,002 10.200% | 344,706 (+14.37%) | Filing History |
| 2024-02-13 4:59 pm Purchase | 2023-12-29 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | The Vanguard Group | 1,458,380 5.460% | 7,955 (+0.55%) | Filing History |
| 2024-02-12 6:09 pm Sale | 2023-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | Nikko Asset Management Americas, Inc. | 1,320,652 4.940% | -128,408 (-8.86%) | Filing History |
| 2024-02-05 06:08 am Sale | 2023-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | Sumitomo Mitsui Trust Group, Inc. | 1,320,652 4.940% | -128,408 (-8.86%) | Filing History |
| 2024-01-29 4:01 pm Purchase | 2023-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | ARK Investment Management LLC | 2,047,687 7.660% | 35,258 (+1.75%) | Filing History |
| 2024-01-25 1:48 pm Purchase | 2023-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | BlackRock Inc. BLK | 2,398,296 9.000% | 513,411 (+27.24%) | Filing History |
| 2024-01-25 07:48 am Sale | 2023-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | STATE STREET CORP STT | 1,629,666 6.100% | -38,259 (-2.29%) | Filing History |
| 2024-01-17 2:43 pm Purchase | 2023-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | FEDERATED HERMES INC. FHI | 4,711,512 17.630% | 471,958 (+11.13%) | Filing History |
| 2023-10-10 11:20 am Sale | 2023-09-30 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | STATE STREET CORP STT | 1,667,925 6.270% | -589,921 (-26.13%) | Filing History |
| 2023-02-10 10:48 am Sale | 2022-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | ARK Investment Management LLC | 2,012,429 7.580% | -460,201 (-18.61%) | Filing History |
| 2023-02-10 10:29 am Purchase | 2022-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | Nikko Asset Management Americas, Inc. | 1,449,060 5.450% | 91,588 (+6.75%) | Filing History |